To continue reading this article, you must have a paid membership.
Existing paying members, please log in to access the full story.
Regulatory filings show that Staples owner Sycamore Partners increased its stake in Essendant to more than 11% on the day the wholesaler implemented a 'poison pill' shareholder rights plan.